An interventional study of Intravenous Methylene blue in Bile Duct Injury, sponsored by University of Oxford. Status unknown at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-12-29.
Sponsored by University of Oxford · Not applicable, Interventional, and Other
Open label prospective, non-randomised proof of principle study assessing the use of methylene blue fluorescence cholangiography.
Exclusion Criteria:
Drug: Intravenous Methylene blue
Methylene blue fluorescence cholangiography during laparoscopic cholecystectomy
Concordance of surgeon anatomy definition with fluorescence outline
Time frame: Intraoperative (At end of laparoscopic cholecystectomy)
Signal to background ratio over time throughout laparoscopic cholecystectomy
Time frame: 0, 10, 20, 30, 40, 50, 60, minutes and at 10 minute intervals thereafter post injection of methylene blue
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Oxford